AbbVie has decided against progressing a recommendation by the Pharmaceutical Benefits Advisory Committee for the listing of VENCLEXTA (venetoclax). …
Latest Video
New Stories
-
CSL opens applications for 2021 Fellowships
June 2, 2020 - - Latest News -
Emgality 'inactive' but Lilly still working on listing
June 2, 2020 - - Latest News -
Australian company updates on trial with MSD's Keytruda
June 2, 2020 - - Latest News -
Positive update for BioMarin haemophilia gene therapy
June 2, 2020 - - Latest News -
COAG abolished by the National Cabinet - now what?
June 1, 2020 - - Comment -
COVID-19: Several vaccines likely of 'variable' efficacy
June 1, 2020 - - Latest News -
June PBS - new asthma and myeloma listings
June 1, 2020 - - Latest News